Abstracts tagged "Dual energy x-ray absorptiometry (DEXA) and osteoporosis"

Abstract Number: 2231 • 2019 ACR/ARP Annual Meeting
Improving Compliance with Screening for Osteoporosis in Elderly Women
Asad Ullah¹, Shaza Khalid ¹, Nagadarshini Vinod ¹, Asghar Marwat ¹, Ali Hussain ¹, Tom Simunich ¹, Medha Joshi ¹ and Lavanya Vuppu ¹, ¹Conemaugh Memorial Medical Center, Johnstown
Background/Purpose: US Preventive Task Force (USPSTF) recommends screening for osteoporosis in women ≥ 65 years of age with dual-energy X-ray absorptiometry (DEXA) scan. There was…
Abstract Number: 2234 • 2019 ACR/ARP Annual Meeting
Osteoporosis Screening in a Resident-Driven Clinic of a Large Academic Hospital
Anam Umar¹, Titilope Olanipenkun ¹, Hiu Sze Kwong ¹, Chelsy Harris ¹, Amber Faquih ², Muhammad Bilal ¹ and Chinedu Ivonye ¹, ¹Morehouse School Of Medicine, Atlanta, ²Emory University School Of Medicine, atlanta
Background/Purpose: Osteoporosis is associated with fragility fractures and represents a significant public health problem. The United States Preventive Services Task Forces (USPSTF) recommend dual-energy x-ray…
Abstract Number: 2514 • 2017 ACR/ARHP Annual Meeting
When Should Lateral Dexa be Used to Measure Spine Bone Mineral Density in Axial Spondyloarthritis Patients: A Cross-Sectional Study
Sizheng Zhao^1,2, Daniel Thong³, Eleanor Quilliam², Stephen Duffield¹, Kai-Wei Yin³ and Nicola Goodson^1,2, ¹Musculoskeletal Biology 1 Department, University of Liverpool, Liverpool, United Kingdom, ²Aintree University Hospital, Liverpool, United Kingdom, ³University of Liverpool, Liverpool, United Kingdom
Background/Purpose: Osteoporosis and vertebral fractures are recognized complications in axial spondyloarthritis (axSpA). Anteroposterior (AP) DEXA is commonly used to assess spinal bone mineral density (BMD)…
Abstract Number: 227 • 2014 ACR/ARHP Annual Meeting
Increasing Fat-Mass May Reverse Bone Loss As Detected By DXA Scan
William Hedges¹ and Marwan Bukhari^2,3, ¹Foundation Programme, Royal Lancaster Infirmary, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster, United Kingdom, ²Lancaster Medical School, Lancaster University, Lancaster, United Kingdom, ³Rheumatology, Royal Lancaster Infirmary, Lancaster, United Kingdom
Background/Purpose: Low body mass index (BMI) is a known risk factor for loss of bone mineral density (BMD). It is a part of the FRAX…
Abstract Number: 53 • 2014 ACR/ARHP Annual Meeting
Spine-Hip Diagnostic Discordance in the United Arab Emirates
Nicholas Wilson, Lidia Sanchez Riera, Iman Hobeldin, Salman Waheeduddin, Nehad Ibrahim, Suneetha Gonuguntla, Tahir Khan, Ritu Aneja, Samer Nuhaily and Mustafa Al Maini, Mafraq Hospital, Abu Dhabi, United Arab Emirates
Background/Purpose Diagnostic discordance for osteoporosis is the presence of different T-scores in two skeletal sites in the same subject leading to different WHO diagnostic categories. Discordance is defined…
Abstract Number: 2442 • 2012 ACR/ARHP Annual Meeting
Screening of Osteoporosis in Men Age 70 and Older: A Need for Increased Awareness
Sian Yik Lim¹, Kenneth Nugent², Joon Hee Lim¹, Hoda Mojazi Amiri¹, Rie Okamura¹ and Dan Nguyen¹, ¹Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, ²3601, Texas Tech University Health Sciences Center, Lubbock, TX
Background/Purpose: The National Osteoporosis Foundation (NOF) currently recommends osteoporosis screening with bone mineral density (BMD) testing in men age 70 and older, regardless of clinical…
Abstract Number: 1557 • 2012 ACR/ARHP Annual Meeting
What Percentage of Postmenopausal Women Younger Than Age 65 Years Have Low Bone Mineral Density At a Family Health Center?
Marvin Vaishnani¹ and Feyrouz T. Al-Ashkar², ¹Rheumatic and Immunologic diseases, Cleveland Clinic,Lorain Institute, Lorain, OH, ²Rheumatic and Immunologic Diseases, Cleveland Clinic,Lorain Institute, Lorain, OH
Background/Purpose: Many younger women, < 65 years of age may have low bone mineral density (BMD) that remains undetected in clinical practice due to following…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].